Even though nonepileptic seizures (NESs) occur in approximately 20% of patients admitted to epilepsy inpatient units and are easily confused with epileptic seizures (1), our understanding of NESs is grossly incomplete. The terminology and classification scheme for this group of disorders are confusing. The epidemiology of NESs has not been adequately studied. The best diagnostic approaches remain to be elucidated, the treatment for psychogenic NESs is essentially in its infancy, and the economic impact of NESs is unknown. In short, there is much work to do. This editorial provides a road map for further progress.